Michael J Lyons Selected Research

Michael J Lyons Research Topics

Disease

8	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2011
8	Cognitive Dysfunction 01/2020 - 07/2014
5	Substance-Related Disorders (Drug Abuse) 01/2019 - 12/2002
4	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 12/2021 - 11/2005
4	Alcoholism (Alcohol Abuse) 10/2008 - 09/2002
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 12/2020
2	Hypertension (High Blood Pressure) 01/2016 - 03/2014
2	Dementia (Dementias) 07/2014 - 10/2013
2	Antisocial Personality Disorder (Antisocial Personality) 06/2007 - 12/2002
1	Stroke (Strokes) 01/2022
1	Wounds and Injuries (Trauma) 12/2021
1	Neurodevelopmental Disorders 10/2021
1	Genomic Instability 10/2021
1	Hypercholesterolemia 01/2021
1	Sleep Apnea Syndromes (Sleep Apnea) 01/2021
1	Erectile Dysfunction 01/2021
1	Movement Disorders (Movement Disorder) 01/2021
1	Atrophy 01/2021
1	Carcinogenesis 12/2020
1	Neoplasms (Cancer) 12/2020
1	Neurologic Manifestations (Neurological Manifestations) 12/2020
1	Parkinson Disease (Parkinson's Disease) 10/2019
1	Epilepsy (Aura) 11/2018
1	Thrombocytopenia (Thrombopenia) 10/2018
1	Insulin Resistance 12/2015
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2014
1	Psychological Trauma 10/2013
1	Turner Syndrome (Turner's Syndrome) 04/2013
1	Myotonia Congenita (Thomsen Disease) 05/2010
1	Jet Lag Syndrome 03/2010
1	alpha-Mannosidosis 11/2007
1	Opioid-Related Disorders (Opiate Addiction) 10/2007
1	Conduct Disorder (Conduct Disorders) 06/2007
1	Tobacco Use Disorder (Nicotine Dependence) 06/2007
1	Heroin Dependence (Heroin Abuse) 09/2006
1	Mental Disorders (Mental Disorder) 03/2005
1	Multiple Sclerosis 03/2005
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 04/2003
1	Weight Gain 04/2003
1	Cocaine-Related Disorders (Cocaine Addiction) 03/2003
1	Marijuana Abuse (Cannabis Abuse) 12/2002
1	Schizophrenia (Dementia Praecox) 11/2002
1	Marijuana Use 09/2002

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
5	Nicotine FDA Link 04/2018 - 09/2002
4	ApolipoproteinsIBA 01/2021 - 10/2013
3	Apolipoproteins E (ApoE)IBA 01/2021 - 01/2011
3	Illicit Drugs (Recreational Drugs)IBA 09/2006 - 09/2002
2	Genetic Markers (Genetic Marker)IBA 12/2021 - 04/2013
2	Biological ProductsIBA 04/2012 - 11/2005
2	4-aminospiroperidolIBA 06/2007 - 12/2002
1	Interleukin-15 (Interleukin 15)IBA 01/2022
1	microtubule-associated protein 1B (MAP5)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 10/2021
1	Double-Stranded RNA (RNA, Double Stranded)IBA 10/2021
1	C-Reactive ProteinIBA 01/2021
1	Prednisolone (Predate)FDA LinkGeneric 01/2021
1	Histones (Histone)IBA 12/2020
1	Amyloid (Amyloid Fibrils)IBA 01/2020
1	Indicators and Reagents (Reagents)IBA 11/2019
1	Dopamine (Intropin)FDA LinkGeneric 10/2019
1	CalciumIBA 11/2018
1	Microfilament Proteins (Actin Binding Proteins)IBA 10/2018
1	Insulin (Novolin)FDA Link 12/2015
1	LipidsIBA 12/2015
1	Glucose (Dextrose)FDA LinkGeneric 12/2015
1	Triglycerides (Triacylglycerol)IBA 12/2015
1	Testosterone (Sustanon)FDA Link 07/2014
1	CholesterolIBA 03/2014
1	Carbamazepine (Tegretol)FDA LinkGeneric 05/2010
1	Hydrocortisone (Cortisol)FDA LinkGeneric 03/2010
1	Neurofibromin 2 (Merlin)IBA 10/2008
1	alpha-Mannosidase (LAMAN)IBA 11/2007
1	Amino Acids FDA Link 10/2007
1	mu Opioid Receptors (mu Opioid Receptor)IBA 10/2007
1	Cocaine (Cocaine HCl)IBA 06/2006
1	Hallucinogens (Psychedelics)IBA 06/2006
1	Opiate AlkaloidsIBA 06/2006
1	Hypnotics and Sedatives (Sedatives)IBA 06/2006
1	Pharmaceutical PreparationsIBA 01/2006
1	Tissue Plasminogen Activator (Alteplase)FDA Link 03/2005
1	AmphetaminesIBA 03/2003

Therapy/Procedure

1	Therapeutics 01/2021
1	Drug Therapy (Chemotherapy) 01/2014